4//SEC Filing
Evolent Health, Inc. 4
Accession 0001628908-17-000034
$EVHCIK 0001628908operating
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:27 PM ET
Size
9.3 KB
Accession
0001628908-17-000034
Insider Transaction Report
Form 4
WIGGINTON STEVE
Chief Development Officer
Transactions
- Sale
Class A Common Stock
2017-07-03$25.07/sh−6,000$150,420→ 12,411 total - Exercise/Conversion
Class A Common Stock
2017-07-03$3.84/sh+6,000$23,040→ 18,411 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2017-07-03−6,000→ 405,680 totalExercise: $3.84Exp: 2024-04-01→ Class A Common Stock (6,000 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016.
- [F2]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.925-$25.275, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The Class A Common Stock Options exercised vested on October 1, 2014.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001628908
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:27 PM ET
- Size
- 9.3 KB